Latest News about XENE
Recent news which mentions XENE
Applied UV (NASDAQ: AUVI) Effectively Doubles Its Size Following A Merger That Could Help Shape The Industry – A Brief Look At The Company
February 02, 2023
From Benzinga
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
December 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
From Benzinga
Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed
December 06, 2022
Tickers
XENE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
November 28, 2022
From Benzinga
Earnings Scheduled For November 8, 2022
November 08, 2022
From Benzinga
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
November 01, 2022
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
October 19, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
August 29, 2022
From Benzinga
What 4 Analyst Ratings Have To Say About Xenon Pharmaceuticals
August 11, 2022
Tickers
XENE
From Benzinga
Earnings Scheduled For August 9, 2022
August 09, 2022
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
